NCT06952660 2026-04-20
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Pfizer
Phase 4 Recruiting
Pfizer
National Cancer Institute (NCI)
University of British Columbia
International Agency for Research on Cancer
University of Miami
On Target Laboratories, LLC
Rush University Medical Center
Institut d'Investigació Biomèdica de Bellvitge
Mayo Clinic
Fundacion Clinic per a la Recerca Biomédica